An Ecosystem for the Modern R&D Lifecycle
Stop fragmenting your research across disconnected tools. HubMed™™ provides a seamless digital thread from In-silico compound discovery to audit-proof clinical evaluation. Bridge the "fragmentation gap" and reduce your R&D timelines by up to 70%.
Solving the Complexity of MedTech, Biotech, and Device R&D
Traditional R&D is bottlenecked by manual molecule screening and an overwhelming "data noise" of scientific literature. HubMed acts as your digital scientific partner, providing a modular architecture that ensures Audit-Proof Data Continuity.
Structured Scientific Rigor
Every insight is powered by the PICO framework, ensuring evidence is traceable, objective, and defensible.
Automated Workflow Continuity
Move from preclinical data straight into your Clinical Evaluation Report (CER) without losing a single data point.
Built for Regulatory Scrutiny
Our solutions are designed to meet the strict standards of the 7-Step Notified Body Workflow and EUDAMED requirements.
Adam | Preclinical In-Silico Research
Early-stage compound discovery and toxicological safety profiling.
Accelerated Molecule Screening: Rapidly identify bioactive compounds for Nutraceuticals and Cosmetics.
In-Silico Toxicity Prediction: Mitigate formulation failures early by forecasting potential adverse effects and molecular stability before wet-lab testing.
Innovation: Transition from "predicting" to "creating" innovative molecular leads.
Medea | Clinical Evaluation & Compliance
End-to-end clinical evaluation management for medical devices under EU MDR.
Automated Literature Screening: Eliminate screening fatigue with systematic, multi-database literature searching (PubMed/MEDLINE, Embase) built directly into your workflow.
70% Faster CER Maintenance: Move away from stagnant Word/Excel repositories. Centralize evidence appraisal in a secure system that automatically tracks version control and drastically reduces human workflow bottlenecks.
Notified Body & Annex XIV Alignment: Standardize clinical evidence reports to systematically eliminate 'Rounds of Questions' (RAQs) and permanently safeguard your files against compliance audits.
70% Resource & Cost Savings: Slash literature review and appraisal times from an industry average of 42 hours down to 12 hours per CER, translating into massive operational cost reductions.
The Cost of Non-Compliance
With 75% of Notified Body submissions reported as incomplete, delays are no longer an option. Every month of certification delay costs MedTech companies up to €250K in lost market opportunities, alongside devastating non-compliance penalties. HubMed ensures your lifecycle—from preclinical data to final CER—is audit-ready
Frequently asked questions
Here are some common questions about our solutions.
Yes. HubMed is a modular ecosystem. You can start with Adam for bioactive discovery or deploy Medea to resolve immediate regulatory complexity in your clinical evaluation.
Beyond the 70% time reduction, HubMed provides a clear ROI by mitigating the risk of failed audits, market blocks, and regulatory rework.
Absolutely. We provide dedicated modules for EUDAMED readiness, new supply interruption obligations (MDCG 2024-16), and legacy device transition management through 2029.
Unify Your R&D Today
Move from fragmented documentation to a system that ensures compliance and resolves complexity.